Japan's Hisamitsu to buy US Noven for $428 million

Hisamitsu becomes the fourth Japanese pharmaceutical company to announce a US acquisition in the recent past, as it makes a tender offer for transdermal and women's health company Noven.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition